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siRNATRP proteins form ion channels which are activated following receptor stimulation. In T-cell lines, expression
data of TRP proteins have been published. However, almost no data about TRP expression is available in
primary human T-cells. Using RT-PCR and quantitative RT-PCR, we compare the expression of TRPmRNA in 1)
human peripheral blood lymphocytes, which are a mix of mostly mono-nuclear blood lymphocytes but
contain other leucocytes, 2) a pure human CD4+ T-helper cell population in the resting (=naïve) and
activated (=effector) state, and 3) two commonly used CD4+ Jurkat T-cell lines, E6-1 and parental. To mimic
physiological cell stimulation, we analyzed TRP expression in primary human cells in a quantitative way over
several days following formation of an immunological synapse through stimulation with antibody-coated
beads. The TRP expression proﬁle of primary human T-cells was signiﬁcantly different from Jurkat T-cells.
Among the TRP mRNAs of the TRPC, TRPM, and TRPV family, we found consistent expression of TRPC1, TRPC3,
TRPV1, TRPM2, and TRPM7 in primary human CD4+ T-cells of all analyzed blood donors. Among these, TRPC3
and TRPM2 were strongly up-regulated following stimulation, but with different kinetics. We found that
TRPC3 modulates Ca2+-dependent proliferation of primary CD4+ T-cells indicating that TRPC3 may be
involved in Ca2+ homeostasis in T-cells besides the well-established STIM and ORAI proteins which are
responsible for store-operated Ca2+ entry.i, intracellular Ca2+ concentra-
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The activation of CD4+ T-cells is central to the adaptive immune
response. T-cells are activatedby foreign antigenswhichare transported
to the T-cell zones in lymph nodes by antigen-presenting cells (APC).
Antigens are then presented by the APC through class-II major
histocompatibility (MHC) complexes until they encounter the
corresponding naïve antigen-speciﬁc CD4+ T-cells [1,2]. Antigen
recognition through the T-cell receptor (TCR) induces many signaling
cascades andmolecular re-arrangementswithin T-cells, which together
control the immune response. Subsequent Ca2+ inﬂux through Ca2+
release-activated Ca2+ (CRAC) channels leads to the rise of intracellular
Ca2+ levels with short-term and long-term consequences for T-cell
activation [3]. The formation of the so-called immunological synapse(IS) is a short-term consequencewhereas the expression of interleukin-
2 (Il-2) and other cytokines, an extensive clonal expansion and
differentiation are long-term consequences [3–6].
For a long time, the molecular identity of the Ca2+ channel
responsible for store-operated Ca2+ entry (SOCE) was a mystery since
its ﬁrst electrophysiological characterization in mast cells [7]. In 2005
and 2006, the two key molecules of SOCE have been identiﬁed by
several independent RNA interference (RNAi) screens, STIM1 [8,9]
and ORAI1 [10–12]. There is no doubt that ORAI channels make up
store-operated CRAC channels and STIM1 acts as the Ca2+ sensor.
After the depletion of Ca2+ from the endoplasmic reticulum, STIM1
oligomerizes and translocates to discrete puncta at endoplasmic
reticulum–plasma membrane junctions, thus activating ORAI1, the
pore-forming subunit of the CRAC channel [13–15].
Over a decade, members of the TRP (transient receptor potential)
family were considered as good candidates for the molecular basis of
store-operated Ca2+ entry in many different cell types. Considering
the prominent role of ORAI channels, it appears very unlikely that
TRPs play any direct role in SOCE in T-cells [16]. Many reports point
into the direction that CRAC mediated Ca2+ entry is the only Ca2+-
inﬂux pathway following TCR activation [17–19]. However, evidence
is emerging that other Ca2+ entry mechanisms may exist in T-cells
[20,21]. In addition a potential role of the TRPC subfamily in SOCE is
still controversial [16,22–28].
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TRPM, TRPA, TRPP and TRPML. They form cation-conducting ion
channels which share 6 transmembrane domains (for review see
[29]). The TRPC subfamily are non-selective ion-channels conducting
Na+, K+ and Ca2+ ions. There is a controversial wealth of literature
describing activation and regulation mechanisms of different TRPC
proteins and their contribution to SOCE activity which might at least
be partially explained by using varying over-expressing systems
implicating varying expression levels (summarized in [16]). A general
agreement exists about store-independent activation of the TRPC3/6/
7 subfamily which is gated by diacylglycerol (DAG), a product of
phospholipase C (PLC) hydrolysis of phosphatidylinositol-4,5-bispho-
sphate [30].
Much less is known about members of the TRPC subfamily in
native tissues and their physiological functions. In mice lacking Trpc1,
thapsigargin, carbacholamin and IP3-stimulated SOCE in submandib-
ular glands acinar cells was reduced resulting in impaired salivary
gland ﬂuid secretion [31]. In TRPC3 knock-out mice, it was shown that
TRPC3 functions as a store-operated channel mediating Ca2+ inﬂux in
acinar cells and the deletion of Trpc3 led to reduced frequency of Ca2+
oscillations [32]. Recently, Riccio et al. [33] published that TRPC5
knock-out mice show less fear in response to aversive stimuli than the
wild-type mice. Expression of TRPC1 and TRPC3-C7 was found in
vascular smooth muscle tissue of human, rat and rabbit where they
contribute to receptor-activated channels (TRPC3, TRPC6, TRPC7),
directly stimulated by DAG, or store-operated channels (TRPC1,
TRPC5, TRPC6, TRPC7) forming channels of homo- or heterotetrameric
subunit compositions [34]). In rat ventricular cardiomyocytes, TRPC3
was also found to be closely associated with the Na+/Ca2+ exchanger
(NCX) within the plasma membrane was and it is triggered by PLC
suggesting a mechanism to control cardiac Ca2+ homeostasis [35–37].
In the present study, we have investigated TRP expression of the
three closely related subfamilies TRPC, TRPV and TRPM.We compared
expression in primary peripheral blood lymphocytes, CD3+ T-cells
and Jurkat T-cell lines. To analyze a potential role of TRPs
in development from naïve to effector T-cells, we stimulated CD4+
T-cells with anti-CD3/anti-CD28 coated beads and analyzed the
regulation of expression by quantitative RT-PCR after formation of
an immunological synapse. We found that TRPC3 was highly up-
regulated during stimulation and that down-regulation of TRPC3 with
siRNA reduced not only proliferation of CD4+ T-cells but also resting
Ca2+ in naïve CD4+ T-cells.
2. Materials and methods
2.1. Cells and medium
PBLs were puriﬁed as described previously [38]. CD4+ T-cells were
negatively isolated using the CD4+ Negative Isolation Kit (Invitrogen,
#113.17D) following the manufacturer's instruction. For CD3+ T-cell
isolation by FACS, PBLs were stained with anti-CD3/FITC conjugated
antibody (Dako, #F0818), washed, and 5×107 PBLswere resuspended
in 2.25 ml PBS/2.5% BSA. CD3+ T-cells were sorted to the highest
purity using the single cell mode of a MoFlo cell sorter (Dako).
Following isolation, the purity of CD4+ or CD3+ populations was
analyzed by ﬂuorescence microscopy with anti-CD4/RPE or anti-CD3/
conjugated antibodies. PBLs were stained with anti-CD4/RPE, anti-
CD8/RPE-Cy5 and anti-CD19/FITC and CD3+ T-cells with anti-CD3/
FITC conjugated antibodies (Dako, #R0805, #C7079, #F0768,
#F0818). PBLs and CD4+ T-cells were cultured in AIMV medium
(Invitrogen, #12055-091) supplementedwith 10% FCS. The two Jurkat
T-cell lines, the so called parental Jurkat T-cell line (par, diphtheria
toxin-resistant version of Jurkat T-cells generated by Fanger et al. [39]
and E6-1 (#TIB-152, ATCC) were grown in RPMI-1640 (Invitrogen
#21875-034) and stably expressing TRPC3 HEK-293 cells in D-MEM
medium (including 250 μg/ml G418, Invitrogen #10131-019) supple-mented with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomy-
cin (PAA, #P11-010). Cells were kept at 37 °C (5% CO2, 95% humidity)
and diluted every 2 to 3 days (Jurkat T-cells) or every 3 to 5 days
(HEK-293 cells).
2.2. Reagents
All chemicals not speciﬁcally mentionedwere from Sigma (highest
grade).
2.3. Molecular biology
Isolation of total RNA was carried out using the TRIzol® Reagent
(Invitrogen, #15596018) including 1 μl Glycogen (5 μg/μl, Invitrogen,
#10814-010) according to the manufacturer's protocol. Templates
made from total RNA for conventional RT-PCR were prepared from
6.1×106 to 1.0×108 cells and 1.0–5.3 μg total RNA were reverse
transcribed into cDNA by SuperScript™ II reverse transcriptase
(Invitrogen, #18064-014) including 1 μl RNaseOut, (Invitrogen,
#10777-019) and 1 μl oligo dT Primer (0.5 μg/μl, Invitrogen,
#18418-012) following the manufacturer's instruction. mRNA was
isolated from 1.2–1.7×108 PBLs using FastTrack®2.0 mRNA isolation
kit (Invitrogen, #K1593-02) and 5 μl were used for reverse transcrip-
tion. Non-focal stimulation of 1×108 PBLs with 2 μg/ml PHA (Sigma,
#L9132) and 25 U/ml hIL-2 (Roche, #1204700) for almost 6 days was
used as one method to produce an effector cell population. Total RNA
from human brain (2 μg/reverse transcription, BD, #640981), kidney
(2 μg/reverse transcription, BD, #636529), colon (3.3 μg/reverse
transcription), placenta (2.4 μg/RT) and from mouse eye (1.5 μg/
reverse transcription) was reverse transcribed as described above.
Conventional RT-PCR was carried out in a personal Thermocycler
(Biometra) using TaqPolymerase from Qiagen (#201203) following
standard protocols (20 μl reaction volume, 200 μMdNTPs (Invitrogen,
#18427-013), 1 μM each primer, 1.5 mMMgCl2, 0.5 μl cDNA and 0.5 U
TaqPolymerase). Initial denaturation time was 3 min at 94 °C,
followed by 35 cycles with 45 s denaturation (94 °C), 30 s annealing
(56–60 °C, depending on each primer pair, for TRPC4 and TRPC5
annealing was 45 s) and 30 s elongation (72°, for TRPM6 and TRPM8
elongation was prolonged to 45 s), and a ﬁnal extension of 10 min
(72 °C). If necessary, 1× Q-solution (Qiagen, #201203) was added to
increase speciﬁcity. A 10 μl of each PCR reaction was separated on
standard agarose gel electrophoresis, images were digitized with a gel
documentation system from Herolab. As a marker, the 1-kb Plus DNA
ladder from Invitrogen (#10787-018) was used. PCR fragments were
cloned using pGEM-T-Vector System I (Promega, #A3600) and
conﬁrmed by sequencing (MWG Biotech).
For quantitative RealTime-PCR (qRT-PCR), total RNA was isolated
from 8.0×106 anti-CD3/anti-CD28 bead stimulated CD4+ T-cells from
day 0 (=unstimulated/naïve CD4+ T-cells) to day 13 (on day 1
6.0×106 CD4+ T-cells were used). In order to normalize for cell
number, 1.5 μl isolated total RNA was used for reverse transcription.
QRT-PCR was carried out in a MX3000 instrument from Stratagene.
cDNA (0.5 μl) and 300 nM of each primer were set into PCR reactions
(25 μl) using Quanti Tect SYBR green kit (Qiagen, #204145) following
the manufacturer's instruction. PCR conditions were: initial denatur-
ation, 15 min, 94 °C; 45 cycles: denaturation, 30 s, 94 °C; annealing,
45 s, 58 °C; elongation, 30 s, 72 °C and ﬁnally a dissociation curve
cycle (60 s, 95 °C; 30 s 55 °C; 30 s 95 °C). Primers were designed using
Primer3 program [40] available at WWW (http://frodo.wi.mit.edu/).
We tested at least three different primer pairs for each gene. PCR
products were analyzed on an agarose gel to detect primer dimers or
other unspeciﬁc bands. The primer pair with lowest CT value and
without any additional band was selected for quantitative PCR. In
addition, we performed a melting curve experiment of each PCR
reaction, to exclude that different products contaminated the
reactions. Expression of genes of interest was normalized to the
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(#NM_000937) and TATA box-binding protein (#NM_003194).
2.4. Anti-CD25 antibody and F-actin cytoskeleton staining
CD4+ T-cells were settled on poly-L-ornithine-coated (0.1 mg/ml
in H2O, Sigma) glass coverslips for 45–60 min. Cells were washed
twice with 1× PBS (pH 7.4), ﬁxed in 3.0% Paraformaldehyde solution
for 20 min, incubated in 1× PBS/0.1 M Glycin for 3 min and washed
once with 1× PBS. To stain for the F-actin cytoskeleton, CD4+ T-cells
were permeabilized with 1× PBS/0.1% Triton. Cells were blocked for
20 min in 1× PBS/2% BSA or 1× PBS/2% BSA/0.1% Triton (following
permeabilization) and incubated for 60 min with anti-CD25/PE (1:10,
Immunotools, #21330254) or stained with Texas Red®-X phalloidin
(1:10, Molecular Probes, #T7471) for 30 min at RT. Cells were washed
thrice with 1× PBS (or 1× PBS/0.1% Triton), rinsed in H2O and
embedded in ProLong antifade reagent (Molecular Probes, #P7481)
on glass slides. CD4+ T-cells were analyzed on the stage of an
Olympus IX 70 microscope equipped with a 20× (UApo/340, N.A.
0.75) or 60× (Uplan FI, N.A. 1.25–0.65, ∞/0.17, oil) objective and ﬁlter
sets from AHF (HQ-Cy3, #F41-007). Acquisition software was T.I.L.L.
Vision.
2.5. Bead stimulation and proliferation experiments
Stimulationwith anti-CD3/anti-CD28 coated beads was performed
as described before [38]. Shortly, polystyrene microparticles
(∅=6 μm, Polysciences, #07312) were coated with azide free anti-
CD3 mAb (Serotec, #MCA463XZ) and anti-CD28 (BD Pharmingen,
#555725) antibodies in a ratio of 1:4 following the manufacturer's
protocol. For Ca2+ imaging experiments Dynabeads® CD3/CD28 were
used (Invitrogen #111-31D). For proliferation experiments in 96 well
plates, CD4+ T-cells were stimulated with anti-CD3/anti-CD28 coated
beads (ratio cell/bead 1:1) and experiments were carried out as
described previously [38]. Proliferation experiments were done under
Ca2+ limiting conditions by the addition of 1.1 mM EGTA [38]. The
number of living cells was determined with CellTiter-Blue™ (Pro-
mega, #G8081) following themanufacturer's instruction. Brieﬂy, 20 μl
CellTiter-Blue™ was added to each well, plates were shortly shaken
and incubated for additional 3 h. Cells were resuspended and
ﬂuorescence was measured with a GeniosPro universal microplate
reader (Tecan) with an excitation of 535 nm and an emission of
590 nm. Instrument settings were: bottom reading, 30 s normal
shaking, 30 s shake settle time, 10 ﬂashes, 40 μs integration time, gain
38. The results were expressed as percentage of relative ﬂuorescence
units (RFU). For day 0, cells were cultured for 1 h at 37 °C, 5% CO2 and
95% before adding 20 μl CellTiter-Blue™ reagent to each well [38].
2.6. Transfection with siRNAs
CD4+ T-cells were transfected using Nucleofector technology
(Lonza) as described by the manufacturer. CD4+ T-cells (5×106)
were transfected with 60 or 100 pmol (for modiﬁed siRNAs) siRNA
(20 μM). The following siRNAs were used: TRPC3siRNAs (Qiagen,
sense 5′ CGUUGUGCU CAA AUAUGAUdT dT 3′, antisense 5′ AUC AUA
UUU GAG CAC AAC G dG dA 3′) and the same sequence modiﬁed by
introducing 2′ deoxy or 2′ methoxy modiﬁcations into the siRNA
(TRPC3 siRNAmod (C3-1mod), sense 5′ r(OMeU-OMeC-CGU UGU
GCU CAA AUA) d(UGA) d(OMeU-OMeT-OMeT) 3′, antisense 5′ d(A) r
(UC AUA UUU GAG CAC AAC G-OMeG-OMeA) 3′), non-silencing
(#1022076, Qiagen) and STIM1siRNA (Dharmacon, #L-011785-00-
0005). On day 1 following transfection, CD4+ T-cells were washed
and resuspended in fresh medium. For single cell Ca2+ imaging
experiments, CD4+ T-cells were transfected on day 0, washed on day
1, stimulated on day 4 (90 h) and measured 1, 2 or 3 days after
stimulation. HEK-293 cells were grown in 6-well plates and cells ineach well were transfected with 0.6 μl siRNA (20 μM) using HiPerfect
(Qiagen, #301705) as described by the manufacturer.
2.7. Single cell Ca2+ imaging
CD4+ T-cells were loaded with 2 μM fura-2/AM (Invitrogen) in
complete medium at 37 °C for 20 min, washed with fresh medium,
stored at 37° for 10 min, and immediately used. Cells were allowed to
settle on poly-L-ornithine-coated (0.1 mg/ml) glass coverslip (1.5–
3×105 cells per coverslip) chambers on the stage of an Olympus IX 70
microscope equipped with a 20× (UApo/340, N.A. 0.75) objective.
Cells were alternately illuminated at 340 and 380 nm with a
Polychrome VMonochromator (Agilent Technologies, TILL Photonics)
using SP 410 as excitation ﬁlter and DCLP 410 as dichroic mirror. The
ﬂuorescence emissions at λN440 nm (LP 440) were captured with a
CCD camera (TILL Imago), digitized, and analyzed using TILL Vision
software. Ratio images and infrared images were recorded at intervals
of 5 s. A sandwiched self-made chamber was used for all measure-
ments which allowed for a complete solution exchange less than 1 s.
To analyze Ca2+ inﬂux in STIM1, TRPC3 or control siRNA down-
regulated CD4+ T-cells, Ca2+ stores were depleted by thapsigargin
(Invitrogen, 1 μM in Ca2+ free Ringer solution), and Ca2+ inﬂux was
monitored following the re-addition of 0.25 mM Ca2+ Ringer solution.
To analyze resting [Ca2+]i in CD4+ T-cells, complete AIMV was used
during the whole experiment. All experiments were carried out at
37 °C.
2.8. Data analysis and statistics
Data were analyzed using TILL Vision (Agilent Technologies, TILL
Photonics), Igor Pro (Wavemetrics) and Microsoft Excel (Microsoft).
To analyze CT values and primer efﬁciencies of quantitative real time
PCR, unprocessed data from MxPro Software were transferred into a
macro written for Igor Pro which was kindly provided by the
Department of Molecular Cell Biology, Saarland University (Peter
Lipp, Gregor Reither and Achim Heinz). SD or SEM was used as
indicated in the ﬁgure legends. In case, data points were normally
distributed, an unpaired two-sided Student's t-test was used. If
normal distribution could not be conﬁrmed, a non-parametric test
(Mann–Whitney) was performed.
3. Results
3.1. Expression of TRPs in primary human T-cells
Ca2+ inﬂux plays a central role during the activation of naïve and
effector T-cells. Whereas the role of STIM and ORAI proteins for Ca2+
inﬂux is undisputed [8–12], the role of members of the TRP family for
Ca2+ signaling pathways is very controversial. In addition, very little
information is available about the expression pattern of TRPC, TRPV
and TRPM subfamilies in primary human T-cells. Due to the limited
availability of speciﬁc and high-afﬁnity antibodies, it is impossible to
obtain a complete expression proﬁle of these channels on protein
level. Therefore, we analyzed mRNA levels of TRPs with conventional
RT-PCR and quantitative RT-PCR. Primer sequences, accession
numbers and PCR conditions for the expression of TRPC1-C7,
TRPV1-V6 and TRPM1-M8 at the mRNA level by conventional RT-
PCR are summarized in Table 1. To obtain a comprehensive view and
coincidentally, to avoid the possibility of donor speciﬁc expression of
single TRPs, we compared expression levels of TRPs in unstimulated
peripheral blood lymphocytes (PBLs) from 8 different donors, in naïve
CD3+ T-cells from 5 different donors, in PHA/IL-2 stimulated PBLs
(=effector cells) from 4 different donors, and in Jurkat T-cell lines
(see Table 2). To quantify the different cell types within the PBL
population, we investigated puriﬁed PBLs by immunohistochemistry
(Fig. 1A). Themajority of cells were CD3 positive (about 75%) whereas
Table 1
Primers and PCR-conditions for the RT-PCR screen of TRPC, TRPV and TRPM subfamilies.
Gene Accession Primer Sequence 5′–3′ Ann. T. Position (from start codon ATG) Length of the RT-PCR product Q-solution
TRPC1 NM_003304, forw 5′ ctatggagaagaactgcagtc 3′ 58 °C 1734–1754 400 bp no
ID:7220 rev 5′ ggaagtcaagtaacgatgcac 3′ 58 °C 2113–2133 no
TRPC3 NM_003305 forw 5′ tgttcaatgcctcagacagg 3′ 58 °C 1202–1221 343 bp yes
ID: 7222 rev 5′ agtgtcacttcactgaggtc 3′ 58 °C 1525–1544 yes
TRPC4 NM_016179 forw 5′ tggaacaatagggaggcgag 3′ 58 °C 2067–2086 580 bp yes
ID: 7223 rev 5′ tctctcaagtggtcctgcag 3′ 58 °C 2627–2646 yes
TRPC5 NM_012471 forw 5′ accagagctatcgatgagcc 3′ 60 °C 1630–1649 951 bp yes
ID: 7224 rev 5′ actgggttcagacatatgacc 3′ 60 °C 2560–2580 yes
TRPC6 NM_004621 forw 5′ cttttgctgaaggcaagagg 3′ 58 °C 554–573 457 bp yes
ID: 7225 rev 5′ ctgcacagatcaaggagtcc 3′ 58 °C 991–1010 yes
TRPC7 NM_020389 forw 5′ ctgcacaatgtctcgcttc 3′ 58 °C 1534–1552 655 bp yes
ID: 57113 rev 5′ tgaggcacatcttgattctc 3′ 58 °C 2168–2188 yes
TRPV1 AY131289 forw 5′ acacacctgatggcaaggac 3′ 58 °C 2192–2211 232 bp yes
ID: 7442 rev 5′ agactgcctatctcgagcac 3′ 58 °C 2402–2421 yes
TRPV2 NM_016113 forw 5′ aagcggaggttggaaactcc 3′ 58 °C 1271–1290 455 bp no
ID: 51393 rev 5′ cactgactctgtggcattgg 3′ 58 °C 1706–1725 no
TRPV3 NM_145068 forw 5′ tgcctgacttcctcatgcac 3′ 58 °C 461–480 627 bp yes
ID: 162514 rev 5′ gactgaggatgtacttcagg 3′ 58 °C 1068–1087 yes
TRPV4 NM_021625 forw 5′ acattgtcaactacctgacgg 3′ 58 °C 896–916 543 bp yes
ID: 59341 rev 5′ acaggtaggagaccacgttg 3′ 58 °C 1419–1438 yes
TRPV5 NM_019841 forw 5´ cagagaacaagactgggacc 3´ 58 °C 72–91 471 bp yes
ID: 56302 rev 5′ tccatgctcaatgagcagc 3′ 58 °C 540–558 yes
TRPV6 NM_018646 forw 5′ caagttgctcaagtatgagg 3′ 58 °C 186–205 373 bp yes
ID: 55503 rev 5′ tccatgctcaatgagcagc 3′ 58 °C 540–558 yes
TRPM1 NM_002420 forw 5′ agtggaggaagaaactgacc 3′ 58 °C 1116–1135 264 bp yes
ID: 4308 rev 5′ aggctgatgtggtaatcagg 3′ 58 °C 1360–1379 yes
TRPM2 NM_003307 forw 5′ gtcaagctcaacgtgcagg 3′ 56 °C 1783–1801 471 bp yes
ID: 7226 rev 5′ attgtccacggagagctgg 3′ 56 °C 2235–2253 yes
TRPM3 AJ505026 forw 5′ gagctcacagcaatgttgg 3′ 56 °C 2482–2500 728 bp yes
ID: 80036 rev 5′ gtctcattctgtccacagg 3′ 56 °C 3191–3209 yes
TRPM4 NM_017636 forw 5′ aggtggagaggattatgacc 3′ 60 °C 1049–1068 573 bp/457 bp yes
ID: 54795 rev 5′ agagcagatacatgctctcc 3′ 60 °C 1602–1621 yes
TRPM5 NM_014555 forw 5′ tgtcacctgcaggatgctg 3′ 58 °C 2463–2481 321 bp yes
ID: 29850 rev 5′ tcatcaatctcgtccagtgg 3′ 58 °C 2764–2783 yes
TRPM6 NM_017662 forw 5′ gttcacttacaccgtgttgg 3′ 58 °C 2565–2584 822 bp yes
ID: 140803 rev 5′ tcttcttggtcgtgaggag 3′ 58 °C 3368–3386 yes
TRPM7 NM_017672 forw 5′ gatgatggtcctgtaagacc 3′ 60 °C 3838–3857 685 bp yes/no
ID: 54822 rev 5′ tgagtgtcttcggtagatgg 3′ 60 °C 4504–4522 yes/no
TRPM8 NM_024080 forw 5′ aacagctgctggtctattcc 3′ 58 °C 1922–1941 922 bp yes
ID: 79054 rev 5′ aggttgtgctcatccagctc 3′ 58 °C 2824–2843 yes
Additional primer pairs for TRPC6.
Gene Accession Primer Sequence 5′–3′ Ann. T. Position (from start codon ATG) Length of the RT-PCR product Q-solution
TRPC6 forw 5′ aggttagctaatcgaggacc 3′ 58 °C 232–251 TRPC6_forw_232 yes
TRPC6 forw 5′ cttttgctgaaggcaagagg 3′ 58 °C 554–573 TRPC6_forw_554 yes
TRPC6 forw 5′ ttcctgtacccttcaatctgg 3′ 58 °C 2279–2299 TRPC6_forw_2279 yes
TRPC6 rev 5′ ctgcacagatcaaggagtcc 3′ 58 °C 991–1010 TRPC6_rev_991 yes
TRPC6 rev 5′ tctggagcgtttcaacatcc 3′ 58 °C 1044–1063 TRPC6_rev_1044 yes
TRPC6 rev 5′ agttcatagcggagacttgag 3′ 58 °C 2673–2693 TRPC6_rev_2673 yes
Gene Primer pair Length of the RT-PCR product
TRPC6 forw/rev 232/991 760 bp
TRPC6 forw/rev 232/1044 813 bp
TRPC6 forw/rev 554/991 438 bp
TRPC6 forw/rev 554/1044 491 bp
TRPC6 forw/rev 2279/2673 395 bp
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CD3+ T-cells, 75.7±13.9% were CD4 positive and 26.8±9.5% CD8
positive T-cells. For the analysis of naïve CD3+ T-cells, CD3+ T-cells
were sorted by FACS under very stringent conditions generating a
100% pure CD3+ T-cell population (see Fig. 1B, 1271 cells out of 1272
cells were CD3 positive analyzed with immunohistochemistry
(99.9%)). To stimulate PBLs, 2 μg/ml PHA and 10–25 U/ml IL-2 were
added in to the medium over 6 days. Following stimulation, the
percentage of CD3+ T-cells increased from 75% to 87.2% (±1.7%)
whereas the percentage of CD19+ B-cells decreased from 14% to 10.8%
(±2.2%) compared to unstimulated PBLs.
Since cells from different blood donors may vary in gene
expression, we tested expression of TRPCs, TRPVs and TRPMs in
individual donors and not in pooled cDNA templates. Fig. 2A showsthe expression of TRPC1, C3 and C6, TRPV1 and V2, TRPM4 and M7 in
all templates tested. Whereas TRPC1 and C3, TRPV1 and V2 and
TRPM7were consistently expressed in cells from all donors, mRNAs of
TRPC6 and TRPM4 were expressed at varying levels in stimulated
PBLs, but no expression was found in naïve CD3+ T-cells. TRPC6 and
TRPM4were, however, clearly detectable in the two Jurkat T-cell lines,
E6-1 and parental. TRPC4 and TRPC5 were neither found in
unstimulated nor in stimulated PBLs nor in CD3+ T-cells, but TRPC4
was strongly detectable in parental but not in E6-1 Jurkat T-cells.
TRPC5 was faintly expressed in both Jurkat T-cell lines, parental and
E6-1 (Fig. 2B). Our expression analysis of TRPC6 in Jurkat T-cells and
PBLs is not consistent with the literature. In contrast to our results,
Gamberucci et al. [41] found TRPC6 expression performing Western-
Blot analysis in PHA/IL-2 stimulated PBL protein lysates. To conﬁrm
Table 2
Expression of TRPs investigated by conventional RT-PCR.
PBLs Stim. PBLs CD3+ par E6-1
TRPC1 8/8 4/4 5/5 1/1 1/1
TRPC2a 8/8 4/4 5/5 1/1 1/1
TRPC3 8/8 4/4 5/5 1/1 1/1
TRPC4 0/8 (P) 0/4 (P) 0/5 1/1 0/1
TRPC5 0/8 (P) 0/4 (P) 0/5 (P) 1/1 1/1
TRPC6 7/8 (1)/4 0/5 1/1 1/1
TRPC7 1/8 0/4 (P) 0/5 (P) 0/1 0/1
TRPV1 8/8 4/4 5/5 1/1 1/1
TRPV2 8/8 4/4 5/5 1/1 1/1
TRPV3 8/8 4/4 3/5 1/1 0/1
TRPV4 8/8 4/4 2/5 (1)/1 0/1
TRPV5 3/8 2/4 2/5 (1)/1 0/1
TRPV6 2/8 2/4 1/5 1/1 1/1
TRPM1 3/8 3/4 (3)/5 (1)/1 (1)/1
TRPM2 8/8 4/4 5/5 1/1 1/1
TRPM3 4/8 (1)/4 1/5 (1)/1 0/1
TRPM4 7/8 3+(1)/4 0/5 1/1 1/1
TRPM5 8/8 4/4 2+(1)/5 1/1 (1)/1
TRPM6 8/8 (3)/4 (1)/5 1/1 1/1
TRPM7 8/8 4/4 5/5 1/1 1/1
TRPM8 0/8 (P) 0/4 (P) 0/5 (P) 0/1 0/1
Expression of TRPs in peripheral blood lymphocytes (PBLs) (8 donors, PBLs), in
stimulated PBLs (4 donors, stim. PBLs), T-cells (5 donors, CD3+) and Jurkat T-cell lines
(par and E6-1 ((#TIB-152, ATCC)) investigated by RT-PCR and conﬁrmed by
sequencing. P: cDNA of n donors (n as indicated) were pooled. Numbers in
parenthesis indicate bands which were almost undetectable on the gel. aTRPC2 is a
possible pseudogene in humans [42].
Fig. 1. Isolation of human PBLs and CD3+ T-cells. A, PBL stained with antibodies against
surface markers on B-cells (anti-CD19/FITC), CD8+ T-cells (anti-CD8/RPE-Cy5) and CD4+
T-cells (anti-CD4/RPE) after isolation from leukocyte reduction ﬁlters. B, Staining of CD3+
T-cells (anti-CD3/FITC) following FACS sorting. Bars are 10 μm.
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naïve CD3+ T-cells (Fig. 2C). None of these combinations ampliﬁed a
fragment of TRPC6, demonstrating that TRPC6 is not expressed in
naïve CD3+ T-cells.
Table 2 summarizes the expression of TRPs in PBLs, naïve CD3+
T-cells, stimulated PBLs, and in Jurkat T-cell lines. Within the TRPC
family, TRPC1 and TRPC3 are consistently expressed. The same is
true for TRPC2 mRNA fragments, which is, however, known to be a
pseudogene in humans [42]. TRPC4, C5, C6 and C7 were neither
detectable in stimulated PBLs (except in one donor, see Table 2) nor
in naïve CD3+ T-cells. Within the TRPV subfamily, TRPV1 and V2,
and within the TRPM subfamily, TRPM2 and TRPM7 were consis-
tently expressed. TRPM8 was not found in any of the templates
tested. The remaining members of the TRPV and TRPM family varied
in the pattern and level of expression. The numbers in parentheses
indicate expression of mRNA fragments at the limit of possible
detection.3.2. Regulation of expression of TRPs in effector CD4+ T-cells following
focal stimulation
CD4+ T-cells play a central regulatory role in the adaptive immune
system. PrimingCD4+T-cellwith anantigen-presenting cell triggers the
stimulation and the subsequent differentiation from naïve to effector
T-cells. Since the regulation of expression levels during these events
might hint to a functional relevance of the affected genes, we analyzed
the expression of different TRPs in CD4+ T-cells following their
stimulation. To address this, we negatively isolated CD4+ T-cells from
Ficoll-gradient puriﬁed PBLs to avoid any pre-stimulation of CD4+ T-
cells. Fig. 3A shows a representative image of anti-CD4 staining of
isolatedCD4+T-cells. The purity of theCD4+T-cell isolationwas 96.8±
0.8%SDCD4+T-cells (840–1700 cells eachdonor) analyzed for the three
different donors used for quantitative RealTime-PCR (qRT-PCR) analysis
(see below). Instead of stimulationwith antigen-presenting cells (APC),
which would have had to be removed before RNA isolation (because
they would contaminate qRT-PCR analysis), focal stimulation wasmimicked by anti-CD3/anti-CD28 coated beads as previously reported
[38]. As shown in Fig. 3B, bead–cell contacts exist already after 7 h and
were still present after 72 h. During stimulation, CD4+ T-cells not only
enlarged their size by a factor of 1.5 (Ø=8.4 μm±0.6 for naïve cells
(n=380) versus 12.5 μm±1.1 (n=76) for effector T-cells as analyzed
in transmission imageswithTILL vision software)but also theamountof
total RNA increased over 4 days by a factor of 6.2±1.9 (n=3). Rapid
F-actin polymerization towards the T-cell-APC contact site is a hallmark
of IS generation [43] and was observed at the CD4+ T-cell-bead contact
site (Fig. 3C) indicating formation of an immunological synapse. The
functionality of T-cell stimulation with anti-CD3/anti-CD28 coated
beads was also conﬁrmed by up-regulation of IL-2R (CD25, [38]) and
proliferation of T-cells (data not shown). Taken together, we conclude
that CD4+ T-cells are efﬁciently stimulated by antibody-coated beads
with molecular and cellular consequences similar to the ones following
stimulation by APC. Thus, we had appropriate starting material to
investigate TRP expression following focal stimulation in CD4+ T-cells.
Within the TRPC, TRPV and TRPM subfamilies, we analyzed the
expression of TRPC1 and C3, TRPV1, TRPM2, M4 and M7 and in
addition the expression of STIM1 and ORAI1 in antibody-coated bead
Table 3
Primer and PCR-conditions used for the quantitative RT-PCR.
Gene Accession Primer Sequence 5′–3′ Ann. T. Position
(from start codon ATG)
Length of the
PCR product
TRPC1 NM_003304, forw 5′ tctggtatgaagggttggaa 3′ 58 °C 1223–1242 139 bp
ID:7220 rev 5′ tccttccgatcagcaaaatc 3′ 58 °C 1342–1361
TRPC3 NM_003305 forw 5′ ggaaggactgtaaaggaca 3′ 56 °C 1711–1729 195 bp
ID: 7222 rev 5′ cacaacggaagtcacttca 3′ 56 °C 1887–1905
TRPV1 AY131289 forw 5′ accacctggaacaccaacgt 3′ 62 °C 2251–2270 178 bp
ID: 7442 rev 5′ gctgagcagactgcctatct 3′ 62 °C 2409–2428
TRPM2 NM_003307 forw 5′ atgcctttggcgacatcgt 3′ 58 °C 374–392 179 bp
ID: 7226 rev 5′ cggcttcatgttgaagttct 3′ 58 °C 533–552
TRPM4 NM_017636 forw 5′ gtatctgctctcggacaag 3′ 58 °C 1611–1629 160 bp
ID: 54795 rev 5′ aagagctgaggaaactgcat 3′ 58 °C 1751–1770
TRPM7 NM_017672 forw 5′ ccagcaaatctaggagaaga 3′ 58 °C 5380–5399 150 bp
ID: 54822 rev 5′ caaatctgaaggctcatcct 3′ 58 °C 5510–5529
ORAI1 NM_032790 forw 5′ atgagcctcaacgagcact 3′ 58 °C 190–218 160 bp
ID: 84876 rev 5′ gtgggtagtcgtggtcag 3′ 58 °C 332–349
STIM1 NM_003156 forw 5′ cagagtctgcatgaccttca 3′ 60 °C 766–785 125 bp
ID: 6786 rev 5′ gcttcctgcttagcaaggtt 3′ 60 °C 871–890
RNAPol NM_000937 forw 5′ ggagattgagtccaagttca 3′ 58 °C 3208–3227 134 bp
ID: 5430 rev 5′ gcagacacaccagcatagt 3′ 58 °C 3323–3341
TBP NM_003194 forw 5′ cggagagttctgggattgt 3′ 58 °C 467–485 161 bp
ID: 6908 rev 5′ ggttcgtggctctcttatc 3′ 58 °C 609–627
HPRT1 NM_000194 forw 5′ caatgcagactttgctttcc 3′ 58 °C 425–444 156 bp
ID: 3251 rev 5′ caagggcatatcctacaaca 3′ 58 °C 561–580
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expression of any gene of interest is expressed as 2−ΔCT-values in
relation to two different house keeping genes (HKG), TATA box
binding protein (TBP) and RNA polymerase II (RNAPol). To show
comparable expression levels, relative expression in naïve CD4+ T-
cells (0 days following stimulation, Fig. 4) was set to 1, except for
TRPM4 and TRPC3. Since TRPM4 expression was not detectable at 7 h
following stimulation and it was only detectable in one out of three
donors in naïve CD4+ T-cells and only in two out of three donors at
1 day following stimulation, the relative expression of TRPM4 was set
to 1 two days following stimulation. For TRPC3, expression in naïve
CD4+ T-cells was only found in two donors, but expression level at 7 h
following stimulation was highly comparable to the level of naïve
cells. For that reason relative expression at 7 hwas set to 1. Among the
TRPs analyzed, most of them remained constant at their RNA
expression level over time. Only the expressions of TRPC3 and
TRPM2were strongly regulated over time compared to naïve CD4+ T-
cells, but with different kinetics (Fig. 4). Seven and twenty-four hours
following stimulation, TRPC3 mRNA levels were almost identical in
naïve CD4+ T-cells. Up-regulation of TRPC3mRNAwas observed from
day 1 to days 4–5 following stimulation, which represents the time
window during which naïve CD4+ T-cell develop into effector T-cells
(up-regulation of IL-2R, down-regulation of CD62 and IL-2 secretion,
[38]). The cells showed enlarged cell sizes (see above) and the amount
of total RNA was increased by a factor of around 6 (n=3). In contrast,
TRPM2 mRNA was ﬁrst down-regulated (by a factor of 6 at 7 h
following stimulation), and slightly increased until day 3 (factor of 1.7
at day 3) but was than up-regulated by a factor of around 7–8 until
day 6 following stimulation. The up-regulation of TRPM2 at later time
points (4 to 6 days following stimulation) may represent a mecha-
nism to control survival or death of individual effector T-cells, because
TRPM2 activation by extracellular signals as oxidative stress, H2O2 and
TNF-α can induce apoptosis [44].
The insets in Fig. 4 show that the relative expression levels of
TRPC1, TRPV1 and STIM1 were ﬁrst down-regulated compared to the
level of naïve T-cells, but reached the same level or slightly higher
levels at day 2 to day 5 following stimulation. TRPM4 mRNA was only
consistently expressed after 2 days of stimulation, but expression
levels increased until days 4–5 (up to a factor of 3.4, mean of the
relative expression to both house keeping genes). Compared to thislevel of regulation, the expression of TRPM7 and ORAI1 mRNAs
remained stable over time. The most abundant TRP channel is TRPM7
in CD4+ T-cells. In addition, TRPV1 and TRPV2 (data not shown) have
an almost comparable expression level. TRPC1 is slightly less
expressed than TRPV1 (for original CT values see ﬁgure legend of
Fig. 4). TRPC3 expression is low under resting conditions but is several
fold up-regulated following stimulation with antibody coated beads.
Regulation of expression is summarized in Table 4.
3.3. Down-regulation of TRPC3 reduces proliferation of CD4+ T-cells
Since TRPC3 was found to be up-regulated during T-cell activation
(Fig. 4) and since it was reported to contribute to Ca2+ entry following
TCR stimulation [45], we analyzed its potential function using an
siRNA approach. As a positive control for the siRNA technology in
primary human CD4+ T-cells, we used siRNAs against STIM1. The role
of STIM1 for Ca2+ entry has been clearly established as an activator for
store-operated CRAC/ORAI channels. We found the efﬁciency of
STIM1 siRNA down-regulation to be in the range of 50% on mRNA
level (Supplementary Fig. 1A). To investigate the functional relevance
of STIM1 down-regulation, we analyzed Ca2+ inﬂux in siRNA
transfected effector CD4+ T-cells following depletion of the intracel-
lular stores by thapsigargin (TG) and the re-addition of 0.25 mM Ca2+
(Supplementary Fig. 1B). Ca2+ inﬂux rates were reduced by 54% in
STIM1 siRNA transfected CD4+ T-cells compared to control cells.
Interestingly, not only Ca2+ inﬂuxwas affected but resting [Ca2+]i was
also reduced to about 50% in STIM1 siRNA transfected naïve CD4+
T-cells (Supplementary Fig. 1C, 6 days following transfection, without
stimulation). Resting Ca2+ levels were, however, not reduced in
stimulated cells treated with STIM1 siRNA (compare initial Ca2+
levels in Supplementary Fig. 1B) while CRAC inﬂux was clearly
reduced. The reduction of resting Ca2+ in unstimulated naïve T-cells
indicates that very few if any CRAC channels are activated under these
conditions. Ca2+ stores are not emptied under these conditions
indicating further that CRAC channels should not be active. The
reduction of resting Ca2+ in naïve T-cells thus suggests that CRAC
is not the only Ca2+ inﬂux pathway controlling resting Ca2+ levels in
T-cells.
To analyze the time dependence of STIM siRNA down-regulation,
we have investigated Ca2+-signals on days 1–3 after T-cell
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was not the case on day 3 as shown in the examples and the statistics
of the Ca2+-inﬂux slope and the Ca2+ plateau (Supplementary Fig. 2A,Fig. 3. Focal stimulation of CD4+ T-cells with anti-CD3/anti-CD28 coated beads.
A, Staining of negatively isolated CD4+ T-cells (anti-CD4/RPE) illustrate the purity
of the isolation procedure (96%-97%, see text). B, Trans-illumination images show CD4+
T-cells in contact with antibody-coated beads following 7 (left) and 72 h (right). C,
Staining of the F-actin cytoskeleton with phalloidin-TexasRed (Phalloidin-TR)
demonstrates the rearrangement of the F-cytoskeleton towards the contact site
between a bead and a cell. Bars are 10 μm.B). This ﬁnding correlates well with STIM1 mRNA down-regulation
analyzed by qRT-PCR with the level of mRNA already recovering after
2 days of stimulation (Supplementary Fig. 2C). Subsequently, we
investigated the effect of STIM1 down-regulation in proliferation
experiments, because proliferation is Ca2+-dependent. As expected,
STIM1 siRNA transfected CD4+ T-cells proliferate less compared to
those transfected with control siRNA (Supplementary Fig. 1D).
Next, we analyzed TRPC3 function following the transfection of
CD4+ T-cells with TRPC3 siRNA. Fig. 5A illustrates the efﬁciency of
down-regulation in primary CD4+ T-cells (64.4% reduction at day 2,Fig. 2. Expression analysis of TRPCs, TRPVs and TRPMs in primary human PBLs, CD3+ T-
cells and Jurkat T-cell lines, E6-1 and parental. A, Expression pattern of TRPs in
unstimulated PBLs (8 donors), stimulated PBLs (4 donors), CD3+ T-cells (5 donors) and
Jurkat T-cell lines parental (par) and E6-1 was analyzed by conventional RT-PCR. Stars
indicate templates prepared from mRNA which lead to weaker signals compared to
templates reverse transcribed from total RNA. B, Expression analysis of TRPC4 and
TRPC5 were carried out within the same templates used in A, but templates of single
donors were pooled. C, Expression analysis of TRPC6 in CD3+ T-cells (5 donors pooled)
with 5 different primer pairs (P1–P5). Templates (C) from human brain (for TRPCs,
TRPV1 and V2, TRPM7) and colon (for TRPM4) were used as positive controls. For
details of PCR conditions see also Table 1.
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Fig. 4. Expression analysis of TRPs in CD4+ T-cells over 13 days. The relative expression (2−ΔCT values) of TRPC1, TRPC3, TRPV1, TRPM2, TRPM4 and TRPM7, ORAI1 and STIM1 were
analyzed in three different donors of CD4+ T-cells over 13 days. Time point 0 corresponds to naïve CD4+ T-cells that were stimulated with anti-CD3/anti-CD28 coated beads.
Expression of the gene of interest was normalized to the expression of two different house keeping genes TATA box-binding protein (black rectangle) and RNA Polymerase II (grey
triangle). Data points are presented asmeans±SEM of three different donors. Expression at time point 0was set to 1, except for TRPC3 (expression at 7 hwas set to 1) and for TRPM4
(expression at 48 h was set to 1) due to missing detectable CT values in all of the three donors (corresponding to no expression or expression under the detection level) at earlier
time points. Insets show relative expression levels from 0 to 48 h. Absolute levels of expression (=original CT values without including any reference genes) in naïve CD4+ T-cells
are: 26.4±0.3 (TRPC1); 35.2±1.4 (TRPC3); 24.6 (TRPV1); 28.6±0.7 (TRPM2); 33.0 (TRPM4); 22.2±0.4 (TRPM7), 20.7±0.5 (ORAI1); 20.5±0.3 (STIM1).
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compared to control siRNA transfected CD4+ T-cells). The TRPC3
siRNA was also analyzed in HEK-293 over-expressing TRPC3 cells
(54% reduction in TRPC3 siRNA transfected compared to control
siRNA transfected HEK-293 cells, Supplementary Fig. 3). To analyze
the potential role of TRPC3 in the Ca2+ homeostasis of CD4+ T-cells,
we ﬁrst investigated whether Ca2+ inﬂux was changed in TRPC3
siRNA transfected cells compared to control cells (transfected with
control siRNA). However, we did not see a signiﬁcant difference
when Ca2+ stores were depleted with thapsigargin (Fig. 5B) which
is in agreement with [45] and [26]. Ca2+ inﬂux rates were 4.0 nM
Ca2+/s±0.2 in control siRNA transfected T-cells (n=1303) similar
to 3.8 nM Ca2+/s±0.3 in TRPC3 siRNA transfected T-cells
(n=1046). The Ca2+ plateau was 100.8 nM Ca2+±2.5 in control
siRNA transfected T-cells (n=1303) versus 102.6 nM Ca2+±2.9 inTRPC3 siRNA transfected T-cells (n=1046). However, we found a
reduction of about 20% in the resting [Ca2+]i levels in naïve CD4+ T-
cells 6 days after transfection (Fig. 5C). In addition, we also
observed a reduction of [Ca2+]i in anti-CD3/anti-CD28-coated
bead-stimulated CD4+ T-cells under Ca2+-limiting conditions
(Fig. 5D). A signiﬁcant difference in the Ca2+-signals was measured
with 36 or 56 μM external Ca2+ present. Similarly, we observed a
reduction of proliferation in TRPC3 siRNA transfected CD4+ T-cells
stimulated with anti-CD3/anti-CD28 coated beads under Ca2+-
limiting conditions within the same range (Fig. 5E).
3.4. Conclusions
Very little information is available about the expression of TRP
proteins in primary human T-cells. We found the TRP expression
Table 4
Regulation of expression in anti-CD3/CD28 coated bead stimulated CD4+ T-cells over
14 days.
Regulation of expression in anti-CD3/CD28 coated
bead stimulated CD4+ T-cells over 13 days
TRPC1 +/−
TRPC3 ++b
TRPV1a +/−
TRPM2 ++
TRPM4 +c
TRPM7 +/−
ORAI1 +/−
STIM1 +/−
The regulation of expression of TRPs, ORAI1 and STIM1were analyzed in anti-CD3/CD28
coated bead stimulated CD4+ T-cells by quantitative RT-PCR. Expression was analyzed
as relative expression to two different house-keeping genes (TATA box binding protein
and RNA PolymeraseII A, compare Fig. 4) in three different donors. +/−: no or only
slight regulation; +: upregulation up to 5-fold; ++ upregulation up to 10-fold.
a Expression was investigated in only one donor.
b Expression at 7 h was set to 1.
c Expression at 2 days (48 h) was set to 1.
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Jurkat T-cell lines. Among the TRP mRNAs of the TRPC, TRPM, and
TRPV family, we found consistent expression of TRPC1, TRPC3, TRPV1,
TRPM2, and TRPM7 in primary human CD4+ T-cells. Among these,
TRPC3 and TRPM2 were strongly up-regulated following focal
stimulation of CD4+ T-cells, but with different kinetics. We found
that down-regulation of TRPC3 with siRNA moderately reduced
proliferation of primary CD4+ T-cells. In parallel, resting Ca2+ in
CD4+ T-cells was also reduced.
4. Discussion
In contrast to murine tissues, murine cells, and T-cell lines, in
which expression data of TRP proteins or mRNA have been published
[46–48], very little information is available about the expression of
TRP proteins in human T-cells. We have analyzed the expression of
the TRPC, TRPV and TRPM subfamilies in primary peripheral blood
lymphocytes, unstimulated and stimulated, CD3+ T-cells and the
commonly used Jurkat T-cell lines parental and E6-1. In addition, we
have investigated the regulation of TRPC1 and C3, TRPV1, TRPM2, M4
and M7 and ORAI1 and STIM1 following focal stimulation with
antibody coated beads by qRT-PCR in CD4+ T-cells.
Within the TRPV family, we found TRPV1 and V2 highly and
consistently expressed in all cell types analyzed whereas the
expression of TRPV3, V4, V5 and V6 differed in CD3+ T-cells between
the donors. For instance, TRPV6 was only detected in one donor out of
ﬁve which is maybe due to expression levels close to the detection
limit, but expression was found in both Jurkat T-cell lines. Others have
detected TRPV1, V2, V3 and V4 in human leukocytes [49] and TRPV5
and V6 in primary T-cells using RT-PCR [50], but TRPV6 could not be
foundwith Northern blot technology in human leukocytes [51]. Taken
together with our expression data, it is questionable if TRPV3, V4, V5
and V6 play a prominent role in primary CD3+ T-cells. TRPV1 as well
as TRPV2 are involved in pain and heat sensation [52], but only very
little information is available about their function in cells of the
immune system. In dendritic cells, capsaicin activates TRPV1 and is
involved in the immune responses [53].
Within the TRPM family, only TRPM2 and TRPM7 were
consistently expressed in PBLs and T-cells. TRPM4 was not
detectable in naïve T-cells but in effector CD4+ T-cells and in
Jurkat T-cell lines, which is consistent with the literature [48,54–
56]. Only after 48 h of stimulation, TRPM4 was expressed in CD4+
T-cells in all three donors investigated. Since TRPM4 is a Ca2+
activated non-selective cation channel, TRPM4 might depolarize the
membrane potential in activated T-cells through Na+ inﬂux, thuspreventing a Ca2+ overload in these cells [57,58]. TRPM2 expression
was highly increased 4 days after stimulation but already stably
expressed in naïve T-cells (see Fig. 4 and Table 2). Whether TRPM2,
which is activated by intracellular Ca2+ [59] and by H2O2 [60], has
different physiological functions in naïve or in effector T-cells is not
yet clear.
The published expression data of TRPCs in Jurkat T-cells is
contradictory [41,45,48,61]. We found that the expression pattern of
the TRPC subfamily in primary human T-cells differs signiﬁcantly from
the expression in T-cell lines. We found only TRPC1 and TRPC3 to be
consistently expressed and no expression of TRPC4, C5, C6 and C7 in
primary CD3+ T-cells, which is different from the expression pattern
in the Jurkat cell lines. Due to this discrepancy, one has to be cautious
when using T-cell lines (and probably other cell lines) as a model to
study TRPC channel function.
Using qRT-PCR, we showed that TRPC3 is highly up-regulated in
CD4+ T-cells stimulated with anti-CD3/anti-CD28 coated beads
compared to naïve T-cells whereas TRPC1 and ORAI1 expression
remains almost constant. It has been shown that TRPC1 and TRPC3
channels can assemble in heteromeric complexes [62]. In addition,
STIM1 was shown to directly activate TRPC1 and indirectly TRPC3 by
mediating heteromultimerization of TRPC1 with TRPC3 [63]. We
found that both, STIM1 and TRPC3 down-regulation, reduced resting
intracellular [Ca2+] in naïve CD4+ T-cells and cell proliferation.
However, the effect of STIIM1 siRNA down-regulation was more
dramatic than that of TRPC3. This is not surprising, as STIM1 is a key
player of SOCE [8,9] and TRPC3 is not involved in SOCE [26,45, in
agreement with our results]. The mode of TRPC3 activation is unclear
but appears to be downstream of TCR stimulation [45] and PLC
activation (reviewed in [30]).
We only observed the TRPC3 effect on proliferation under Ca2+
limiting conditions. Since ORAI1 channels are of course dominating Ca2+
signals in T-cells [17],ORAI1 alone is usually sufﬁcient tomediate theCa2+
inﬂux required for proliferation. Under highly Ca2+ limiting conditions,
even the small Ca2+ inﬂux through TRPC3 channels might be required to
drive proliferation. In addition, proliferation depends on cytosolic resting
Ca2+ concentrations analyzed over several days [38] under these
conditions. Since TRPC3 reduces the resting Ca2+ concentration, the
subsequent reduction of proliferation was expected. How TRPC3
contributes to Ca2+ entry in T-cells is presently not clear. There are at
least three different possibilities:
1. TRPC3 activity generates Ca2+ entry by itself. This happens at the
cost of very high Na+ entry and T-cell polarization because TRPC3
channels are considered to be non-selective cation channels.
2. A close association between TRPC3 and the Na+/Ca2+ exchanger
(NCX) as described for HEK-293 [37] could explain TRPC3
dependent Ca2+ entry if Na+ entry through TRPC3 drives NCX in
the reverse mode. However there is no evidence for NXC activity in
T-cells [64].
3. There is some evidence that members of the TRPC family can
interact with STIM and ORAI proteins thus inﬂuencing SOCE
[63]. We have, however, never found a hint that TRPC3 is
activated by store depletion [45], however we can not exclude
this possibility. Ong et al. [27] described a ternary complex of
TRPC1, STIM1 and ORAI1 and reported that it was required for
SOCE. In pull-down assays, it was shown that TRPC3 and TRPC6
physically interact with ORAI1, and ORAI1 was shown to
enhance SOCE in TRPC3 or TRPC6 expressing HEK-293 cells
[65]. Very recently, a model was proposed that ORAI:TRPC
complexes, depending on their localization in or outside lipid
rafts, mediate SOCE or ROCE [66,67]. Given the dominating
importance of the STIM-ORAI dependent Ca2+ entry in T-cells,
one has to be careful to assign premature functions for TRPC
channels in T-cells. Yet, its regulation makes TRPC3 an
interesting candidate to contribute to Ca2+ signaling in T-cells.
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Fig. 5. Analysis of TRPC3 function in CD4+ T-cells with small interfering RNAs (siRNAs). A, TRPC3 is down-regulated in primary TRPC3 siRNA transfected CD4+ T-cells. Cells were
stimulated for 2 days and TRPC3 expression was investigated 1 to 3 days after transfection (TRPC3 siRNAmod (TRPC3, grey); non-silencing, control siRNA (control, black)). TRPC3
expression was calculated relative to the mean of three house-keeping genes TBP, RNAPolymerase II and hypoxanthine phosphoribosyltransferase 1 (HPRT1). Relative expression in
control cells was set to 100%. B, Ca2+ inﬂux was not affected in naïve TRPC3 siRNAmod (TRPC3, grey) compared to control siRNA (control, black) transfected CD4+ T-cells when
stimulated with thapsigargin. Naïve cells (not bead-stimulated) weremeasured 4 days after transfection. C, Analysis of intracellular Ca2+ ([Ca2+]i) under Ca2+-limiting conditions in
siRNA transfected, naïve CD4+ T-cells. Resting Ca2+ is reduced in TRPC3 siRNA transfected CD4+ T-cells (C3-1, grey, n=87) compared to control siRNA transfected CD4+ T-cells
(black, control, n=247) 6 days following transfection by 20% (cells of two different donors, measured in complete AIMVmedium). Bars showmeans±SEM, pb0.001 calculated over
the complete experiment of 600 s. Traces show a representative cell of each TRPC3 siRNA (grey) and control siRNA transfected CD4+ T-cells (black). D, Extracellular [Ca2+] ([Ca2+]ex)
was reduced by the addition of EGTA and corresponding [Ca2+] within themediumwere determined as described [38]. Final [EGTA] added to themedium and ([Ca2+]ex) are given in
the table (below). CD4+ T-cells were stimulated for 2 days with anti-CD3/anti-CD28 antibody-coated beads 4 days after transfection with either TRPC3 siRNA (grey) or control siRNA
(black). Circles show the mean±SEM of 38 to 138 cells of two different donors. E, Proliferation of TRPC3 siRNA (C3-1, grey) was reduced compared to control siRNA (black)
transfected CD4+ T-cells at day 4 following stimulation with anti-CD3/anti-CD28 coated beads. Proliferation wasmeasured under Ca2+ limiting conditions (addition of 1.1 mM EGTA
corresponding to 46 μM free extracellular [Ca2+] [38]) 1 to 5 days after transfection corresponding to days 0, 1, 2, 3 and 4 after stimulation. Relative ﬂuorescence units (RFU) at day 0
were set to 100% and data are shown as means±SEM, numbers of donors (n) are indicated. At day 4, reduction in proliferation was about 10% (p=0.04).
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